We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
A. O. Smith (AOS) Q3 Earnings Miss Estimates, Decline Y/Y
Read MoreHide Full Article
A. O. Smith Corporation (AOS - Free Report) reported disappointing third-quarter 2019 results wherein both earnings and revenues lagged estimates.
The company’s adjusted earnings were 53 cents per share, missing the Zacks Consensus Estimate of 54 cents. Also, the bottom line declined from the year-ago figure of 61 cents.
Inside the Headlines
The company’s sales decreased 3.4% year over year to $728.2 million. The decline was primarily attributable to fall of sales in China. Also, the figure missed the Zacks Consensus Estimate of $757 million.
A. O. Smith Corporation Price, Consensus and EPS Surprise
A.O. Smith’s sales in North America (comprising U.S. and Canadian water heaters and boilers) increased 5.7% year over year to $514.6 million. Higher sales volumes of water heater and boiler products in the United States proved beneficial for the segment.
Segmental operating earnings jumped 15% year over year to $121.6 million. The improvement was primarily driven by higher sales volumes of water heater and boiler, lower steel costs and incremental profits from acquired Water-Right business.
Quarterly sales in Rest of the World (including China, India and Europe) were down 20% year over year to $220.3 million. The decline was primarily attributable to soft consumer demand and above normal channel inventory levels, particularly in China.
Operating earnings at the segment significantly declined to $4.1 million from $39.1 million in the year-ago quarter. Lower sales in China proved detrimental to the segment’s income.
Share Repurchases
In first nine months of 2019, A.O. Smith repurchased around 4.9 million shares for $230 million. At the end of the quarter, the company had approximately 4.1 million shares remaining under the existing discretionary repurchase authority.
Liquidity & Cash Flow
On Sep 30, 2019, A.O. Smith’s cash and cash equivalents totaled $219.4 million compared with $259.7 million as of Dec 31, 2018.
At the end of the reported quarter, long-term debt was $312.4 million compared with $221.4 million as of Dec 31, 2018.
Guidance
Concurrent with third-quarter results, the company revised guidance for 2019. It expects adjusted earnings to lie in the range of $2.25-$2.28 per share compared with the previous estimation of $2.35-$2.41.
Zacks Rank & Key Picks
A.O. Smith currently carries a Zacks Rank #4 (Sell).
Cimpress’ earnings surprise in the last reported quarter was a positive 137.04%.
Brady delivered average positive earnings surprise of 9.68% in the trailing four quarters.
Dover pulled off average positive earnings surprise of 6.70% in the trailing four quarters.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
A. O. Smith (AOS) Q3 Earnings Miss Estimates, Decline Y/Y
A. O. Smith Corporation (AOS - Free Report) reported disappointing third-quarter 2019 results wherein both earnings and revenues lagged estimates.
The company’s adjusted earnings were 53 cents per share, missing the Zacks Consensus Estimate of 54 cents. Also, the bottom line declined from the year-ago figure of 61 cents.
Inside the Headlines
The company’s sales decreased 3.4% year over year to $728.2 million. The decline was primarily attributable to fall of sales in China. Also, the figure missed the Zacks Consensus Estimate of $757 million.
A. O. Smith Corporation Price, Consensus and EPS Surprise
A. O. Smith Corporation price-consensus-eps-surprise-chart | A. O. Smith Corporation Quote
A.O. Smith’s sales in North America (comprising U.S. and Canadian water heaters and boilers) increased 5.7% year over year to $514.6 million. Higher sales volumes of water heater and boiler products in the United States proved beneficial for the segment.
Segmental operating earnings jumped 15% year over year to $121.6 million. The improvement was primarily driven by higher sales volumes of water heater and boiler, lower steel costs and incremental profits from acquired Water-Right business.
Quarterly sales in Rest of the World (including China, India and Europe) were down 20% year over year to $220.3 million. The decline was primarily attributable to soft consumer demand and above normal channel inventory levels, particularly in China.
Operating earnings at the segment significantly declined to $4.1 million from $39.1 million in the year-ago quarter. Lower sales in China proved detrimental to the segment’s income.
Share Repurchases
In first nine months of 2019, A.O. Smith repurchased around 4.9 million shares for $230 million. At the end of the quarter, the company had approximately 4.1 million shares remaining under the existing discretionary repurchase authority.
Liquidity & Cash Flow
On Sep 30, 2019, A.O. Smith’s cash and cash equivalents totaled $219.4 million compared with $259.7 million as of Dec 31, 2018.
At the end of the reported quarter, long-term debt was $312.4 million compared with $221.4 million as of Dec 31, 2018.
Guidance
Concurrent with third-quarter results, the company revised guidance for 2019. It expects adjusted earnings to lie in the range of $2.25-$2.28 per share compared with the previous estimation of $2.35-$2.41.
Zacks Rank & Key Picks
A.O. Smith currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the same space are Cimpress N.V (CMPR - Free Report) , Brady Corporation (BRC - Free Report) and Dover Corporation (DOV - Free Report) . While Cimpress sports a Zacks Rank #1 (Strong Buy), Brady and Dover carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Cimpress’ earnings surprise in the last reported quarter was a positive 137.04%.
Brady delivered average positive earnings surprise of 9.68% in the trailing four quarters.
Dover pulled off average positive earnings surprise of 6.70% in the trailing four quarters.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>